Physician profile
Angelo R Dacus
NPI 1376509539
$56,597.24
in general payments reported to CMS, 2019-2025
20 companies · $2,921 in 2025
The $2,921 reported for 2025 was more than what 87% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $890 · 2021: $11K · 2022: $13K · 2023: $1,527 · 2024: $3,884 · 2025: $2,921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,918 · Honoraria: $1,250 · Consulting Fee: $1,250 · Food and Beverage: $1,146 · Long Term Medical Supply Or Device Loan: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,918.41 |
| Honoraria | $1,250.00 |
| Consulting Fee | $1,250.00 |
| Food and Beverage | $1,146.06 |
| Long Term Medical Supply Or Device Loan | $766.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $15,196.61 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pharmaceutical Business Consultants Limited | $13,100.76 | 2020-2025 | |
| Medartis INC. | $6,300.05 | 2019 | |
| Microaire Surgical Instruments LLC | $5,266.79 | 2019-2022 | |
| Medical Device Business Services, INC. | $4,387.50 | 2021 | |
| Fortis Surgical, LLC | $4,134.65 | 2020-2025 | |
| Stryker Corporation | $1,887.85 | 2024 | Mako, Valor, Swanson |
| Arthrex, INC. | $1,812.84 | 2019-2024 | |
| Supreme Orthopedic Systems, LLC | $1,696.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $967.46 | 2019 | |
| Newclip USA LLC | $764.70 | 2025 | |
| Axogen | $260.79 | 2022-2025 | |
| Ossio INC | $255.92 | 2023 | |
| Depuy Synthes Sales INC. | $245.89 | 2019-2021 | |
| Kerecis Limited | $139.92 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xiros INC | $54.54 | 2025 | |
| Anika Therapeutics, INC. | $36.00 | 2024 | Wristmotion |
| Renerve Ltd | $32.72 | 2025 | Nervalign Nerve Cuff |
| Smith+Nephew, INC. | $32.05 | 2021 | |
| Viiv Healthcare Company | $24.20 | 2024 | Cabenuva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelo Dacus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.